US Medical Innovations Llc Announces Global Agreements with WEM Equipamentos Electrônicos LTDA for Development, Manufacturing and Distribution

March 2012
Biomedical Market Newsletter;3/28/2012, Vol. 21, p1
The article informs that US Medical Innovations LLC (USMI) has entered into new agreements with WEM Equipamentos Electrônicos LTDA. The agreement is aimed at development, distribution and manufacturing of USMI's electrosurgical plasma generators, coagulators, and accessories and related products for use in surgery and endoscopy. USMI develops Canady Plasma line of medical devices in the U.S.


Related Articles

  • Deals roundup.  // Medical Device Daily;2/13/2008, Vol. 12 Issue 30, p5 

    This article reports that Luminex has renewed and expanded the license and supply agreement of Invitrogen for its multiplexed analyte detection technology and systems. Under the deal, the lifetime of the license will be extended and will provide Invitrogen with access to Luminex's...

  • Sectra enters the Saudi Arabian market.  // Medical Device Daily;10/27/2009, Vol. 13 Issue 207, p7 

    The article reports on a distribution agreement signed by Sectra with medical technology company Attieh Medico in Jeddah, Saudi Arabia. Sectra's medical systems in Saudi Arabia will be distributed by Attieh Medico. Included in the deal are the Sectra MicroDose Mammography and Sectra PACS system...

  • Angiotech in deal with Rex to market, distribute vena cava filter.  // Medical Device Daily;3/17/2008, Vol. 12 Issue 52, p5 

    The article reports on the licensing agreement of Angiotech Pharmaceuticals with Rex for exclusive worldwide rights to market and distribute the Option inferior vena cava (IVC) filter. William Hunter, president and CEO of Angiotech, believes in the market potential of the Option IVC filter. An...

  • Agreements/contracts.  // Medical Device Daily;10/29/2009, Vol. 13 Issue 209, p4 

    This article reports on a license agreement entered by Micronics of Washington with Biosearch Technologies of California to produce and sell products from Micronics. The agreement covers fluorophores and quencher dyes for nucleic acid assays from Biosearch. Moreover, Micronics has been granted...

  • Hearing is believing. Roberts, Craig // BRW;8/19/2004, Vol. 26 Issue 32, p58 

    Reports on Melbourne-based technology company Dynamic Hearing's signing of its first licensing deal with Germany's hearing aid manufacturer, Interton Hoergeraete. Product of Dynamic Hearing; Terms of the deal; Appointment of Elaine Saunders as chief executive to lead the commercialization of the...

  • Agreements/contracts.  // Medical Device Daily;5/15/2009, Vol. 13 Issue 93, p6 

    The article reports on a license agreement signed by Tornier with T.A.G. Medical Products for the ArthroTunneler Arthroscopic Transosseous Bone Tunneling System. ArthroTunneler is a single-use device designed to allow surgeons to arthroscopically place precise intersecting tunnels in bone for...

  • Deals roundup.  // Medical Device Daily;9/15/2008, Vol. 12 Issue 197, p3 

    The article reports on the licensing and development agreement entered by OmniSonics Medical Technologies, a developer of devices for use in the treatment of vascular disease with Boston Scientific for technology to treat thromboembolic acute ischemic stroke. Under the agreement, the two...

  • Agreements/contracts.  // Medical Device Daily;4/23/2009, Vol. 13 Issue 77, p4 

    The article reports that Q-Med and Oceana Therapeutics have entered into definitive agreements to license commercialization rights to Deflux and Solesta. The license agreements also include future products that use NASHA technology from Q-Med. Oceana Therapeutics will acquire Q-Med Scandinavia...

  • VALIDITY AND RELIABILITY OF A VIRTUAL REALITY UPPER GASTROINTESTINAL (GI) SIMULATOR. Moorthy, K.; Munz, Y.; Jiwanji, M.; Bonn, S.; Darzi, A. // Gut;Apr2003 Supplement 1, Vol. 52, pA114 

    Background: This study aims to establish the validity and reliability of an upper Gl simulator as a tool for the assessment of endoscopic skills. Methods: Subjects with varying levels of experience undertook 4 cases on the upper Gl simulator. Data on the time taken for the procedure percentage...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics